// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Physicians’ perceptions on gender differences in the diagnosis and management of COPD

Chantal Raherison-Semjen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Osteoporosis

N/A

Data mining Inhaled corticosteroid Beclometasone dipropionate (bdp) equivalent dose from routine primary care records

Chris Newby - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

beclometasone dipropionate

Eligibility for referral to specialist asthma clinics in England: a national database study

John D Blakey - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Inhaled LPS challenge in healthy subjects: a dose escalation study

Alex Mulvanny - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiovascular risk and exercise capacity in COPD

Yousef S Aldabayan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Consistency of aerosol characteristics at low flow rates for a novel mesh nebulizer

John Pritchard - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Atrovent

Prevalence, views and experience of e-cigarette use by COPD patients in The Birmingham COPD Cohort

Matthew Swallow - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Diagnosis of Lower Respiratory Tract Infections using nanopore sequencing

Themoula Charalampous - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Physical Frailty on Pulmonary Rehabilitation and Hospitalisation in COPD

Kola Akinlabi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Prescribed analgesics in pregnancy and the risk of child asthma- a register-based study.

Bronwyn Brew - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Migraine

Acetaminophen

The effect of ambient air pollution on the risk of hospitalisation with bronchiolitis in infants: A systematic review.

Charlotte King - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patients’ ability to use a novel fluticasone propionate/formoterol breath-triggered inhaler (BTI) vs. budesonide/formoterol dry powder inhaler (DPI)

David Bell - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

budesonide + formoterol fuma

Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD

Jaco Voorham - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Physical activity and incidence of restrictive spirometry pattern in adults

Anne-Elie Carsin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Healthcare resource utilisation (HRU) in the Asthma Salford Lung Study (SLS asthma)

Dominy Browning - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Fluticasone furoate

Defining acute asthma severity – how do worldwide asthma guidelines compare?

Ann Mcmurray - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The underlying cause of type 2 respiratory failure affects NIV adherence

Sara Parsons - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Challenges facing parents/caregivers of children with interstitial lung disease (chILD): international survey

Jeanette Boyd - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA

James P. R. Schofield - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Glucocorticoid

Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?

Hon Lin Wu - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Copyright © 2026. QuantiNova All rights reserved